期刊文献+

氟伏沙明与帕罗西汀治疗强迫症的对照研究 被引量:4

A control study of fluvoxamine and paroxetine in the treatment of obsessive-compulsive disorder
下载PDF
导出
摘要 目的比较氟伏沙明与帕罗西汀治疗强迫症的疗效及安全性。方法分别用氟伏沙明和帕罗西汀治疗强迫症患者各36例,采用Yale-Brown强迫量表、汉密尔顿抑郁量表(HAMD)及不良反应量表(TESS)评定疗效和不良反应。结果氟伏沙明和帕罗西汀疗效相似,差异无统计学意义,氟伏沙明起效慢于帕罗西汀,其不良反应也少于帕罗西汀。结论氟伏沙明治疗强迫症安全有效,值得推广。 Objective To compare the efficacy and side effects of fluvoxamineine and paroxetine in the treatment of obsessive-compulsive disorder( OCD). Methods 72 patients with OCD were randomly assigned into fluvoxamineine group and paroxetinegroup. The efficacy was measured with Yale-Brown and Hamilton Depres- sion Scale (HAMD). The side effects were deter-mined by the Treatment Emergent Symptom Scale (TESS). Results There was no significant difference in the efficacy between two groups. The side effects of fluvoxamineine were lower than those of paroxetine. Conclusion Fluvoxamineine in the treatment of OCD is effective and safe.
出处 《中国实用医药》 2008年第18期46-47,共2页 China Practical Medicine
关键词 氟伏沙明 帕罗西汀 强迫症 不良反应 Fluvoxamineine Paroxetine OCD Adverse reaction
  • 相关文献

参考文献3

二级参考文献27

  • 1刘建新,王晓峰,李拴德,王小亚,张红宾,李迎国,姜克明.立体定向手术对强迫症患者脑脊液5-羟色胺含量的影响[J].中国行为医学科学,2004,13(5):538-538. 被引量:3
  • 2[1]Yasui FN, Kondo T, Mihara K, et al. Fluvoxamine dose-dependent interaction with haloperidol and the effects on negative symptoms in schizophrenia [ J ]. Psychopharmacology ( Berl ),2004,171(2) :223 - 227. 被引量:1
  • 3[2]Kanda H, Yasui FN, Fukasawa T, et al. Interaction study between fluvoxamine and quazepam[J]. J Clin Pharmacol, 2003 , 4 3 (12 ) :1392 - 1397. 被引量:1
  • 4[3]Stein DJ,Westenberg HG,Yang H,et al. Fluvoxamine CR in the long-term treatment of social anxiety disorder: the 12-to 24-week extension phase of a multicentre, randomized, placebo-controlled trial[J]. Int J Neuropsychopharmacol,2003,6(4) :317 - 323. 被引量:1
  • 5[4]Zanardi R, Cusin C, Rossini D, et al. Comparison of response to fluvoxamine in nondemented elderly compared to younger patients affected by major depression[J ]. J Clin Psychopharmacol, 2003,23(6) :535 - 539. 被引量:1
  • 6[5]Dalery J, Honig A. Fluvoxamine versus fluoxetine in major depressive episode: a double-blind randomized comparison[ J ]. Hum Psychopharmacol,2003,18(5): 379 - 384. 被引量:1
  • 7[6]Hollander E,Koran LM, Goodman WK, et al. A double-blind,placebo-controlled study of the efficacy and safety of controlledrelease fluvoxamine in patients with obsessive-compulsive disorder [J] .J Clin Psychiatry,2003,64(6) :640 - 647. 被引量:1
  • 8[7]Silver H, Aharon N, Kaplan A. Add-on fluvoxamine improves primary negative symptoms: evidence for specificity from response analysis of individual symptoms [ J ]. Schizophr Bull, 2003, 29(3):541-546. 被引量:1
  • 9Kennedy JS,Gwirtsman HE,Schmidt DE,et al.Serial cerebrospinal fluid tryptophan and 5-hydroxy indoleacetic acid concentrations in healthy human subjects[J].Life Sci,2002,71(14):1703 被引量:1
  • 10Thoren P,Abserg M,Cronholm B,et al.Clomipraminen treatment of obsessive-compulsive disorder I A controlled clinical trial[J].Arch Gen Psychiatry,1980,37:1281 被引量:1

共引文献29

同被引文献33

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部